twinklea five-year-old French startup that has developed AI software to help radiologists diagnose and detect bone trauma lesions in scans among other conditions, has raised 27 million euros ($29.5 million) in a Series B funding round.
Founded in 2017, Gleamer’s core staple BoneView the software is billed as an “AI companion for bone trauma radiography,” helping radiologists direct radiologists to scan areas that might point out easy-to-miss abnormalities. visible to the naked eye. It also grows BoobsView to detect lung disease.
All Gleamer products have been certified for use in Europe, while BoneView has received FDA license in the US The company claims to have approximately 6,500 users across 650 organizations in 24 countries.
scan do
Gleamer is looking to capitalize on a growing need for medical imaging services, driven in part by increase in chronic diseases, underfunded health care systemand aging population.
Just last week, the British Government announced a new £21 million fund to extend AI deeper into the NHS, with a particular focus on medical imaging. Elsewhere, many startups have raised large amounts of venture capital (VC) to bring new technologies and services to radiology, including portable x-ray machine, private medical imaging marketand so-called “decision support” software powered by AI.
Paris-based Gleamer has now raised a total of 36 million euros since its founding, and with its latest funding round, the company says it plans to expand its product portfolio to include CT scans and mammography, while expanding its team in both Europe and the United States
Gleamer’s Series B round was co-led by Supernova Invest and Heal Capital, with participation from XAnge, Elaia, Bpifrance, F3A, MACSF, Crista Galli Ventures, UI Investissement and “several European radiologists”.
